Home > Drug Search >
  • company_query: Bavarian Nordic
  •   > 
Drug Filter
Category:
chemistry (6) biology (25)
Status:
Approved (1) Withdrawn (1) Phase Ⅲ (6) Phase Ⅱ (12) Phase Ⅰ (11)
Clinical Stage:
Pending (1) Active (21) Discontinued (7)
Bio-Type:
Gene therapy (1) Vaccine (19) Recombinant cytokines (1) Whole antibody (2) ADC (1)
Indication:
Acute myeloid Leukemia (AML) (1) Amyotrophic lateral sclerosis (ALS) (1) Bladder cancer (1) Breast cancer (3) Dry eye disease (1) Endometrial cancer (1) Eye disorders (1) Gastric cancer (1) Cytomegalovirus infections (2) HIV infection (4) Ischaemia (1) Melanoma (1) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (2) Haemophilus infection (1) Pertussis (1) Prostate cancer (1) Solid tumours (2) Yellow fever (1) Head and neck cancer (1) Influenza A virus infections (2) Bacteraemia (1) Anthrax (1) Glioblastoma (1) Systemic sclerosis (1) Respiratory syncytial virus infection (1) Corneal disorders (1) Acute kidney injury (1) Diabetic neuropathy (1) Cardiac reperfusion injury (1) Ebola virus disease (EVD) (2) Inflammation (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top